Correlation Between SentinelOne and NextCell Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both SentinelOne and NextCell Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SentinelOne and NextCell Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between SentinelOne and NextCell Pharma AB, you can compare the effects of market volatilities on SentinelOne and NextCell Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SentinelOne with a short position of NextCell Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of SentinelOne and NextCell Pharma.

Diversification Opportunities for SentinelOne and NextCell Pharma

-0.56
  Correlation Coefficient

Excellent diversification

The 3 months correlation between SentinelOne and NextCell is -0.56. Overlapping area represents the amount of risk that can be diversified away by holding SentinelOne and NextCell Pharma AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NextCell Pharma AB and SentinelOne is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SentinelOne are associated (or correlated) with NextCell Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NextCell Pharma AB has no effect on the direction of SentinelOne i.e., SentinelOne and NextCell Pharma go up and down completely randomly.

Pair Corralation between SentinelOne and NextCell Pharma

Taking into account the 90-day investment horizon SentinelOne is expected to under-perform the NextCell Pharma. But the stock apears to be less risky and, when comparing its historical volatility, SentinelOne is 1.66 times less risky than NextCell Pharma. The stock trades about -0.2 of its potential returns per unit of risk. The NextCell Pharma AB is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest  280.00  in NextCell Pharma AB on December 11, 2024 and sell it today you would earn a total of  54.00  from holding NextCell Pharma AB or generate 19.29% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy95.24%
ValuesDaily Returns

SentinelOne  vs.  NextCell Pharma AB

 Performance 
       Timeline  
SentinelOne 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days SentinelOne has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
NextCell Pharma AB 

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in NextCell Pharma AB are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, NextCell Pharma unveiled solid returns over the last few months and may actually be approaching a breakup point.

SentinelOne and NextCell Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with SentinelOne and NextCell Pharma

The main advantage of trading using opposite SentinelOne and NextCell Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SentinelOne position performs unexpectedly, NextCell Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NextCell Pharma will offset losses from the drop in NextCell Pharma's long position.
The idea behind SentinelOne and NextCell Pharma AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Other Complementary Tools

Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators